Volume 17, Issue 3, Pages (October 2016)

Slides:



Advertisements
Similar presentations
Volume 3, Issue 4, Pages (April 2013)
Advertisements

From: Causes and Metabolic Consequences of Fatty Liver
Volume 20, Issue 5, Pages (November 2014)
Volume 9, Issue 3, Pages (March 2009)
Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome  Li Chen, M.S., Wen.
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Figure 1 Pathophysiological aspects of insulin
Volume 20, Issue 3, Pages (July 2017)
Vascular biology of metabolic syndrome
Obesity Heats Up Adipose Tissue Lymphocytes
Volume 3, Issue 4, Pages (April 2013)
Figure 3 Candidate signalling pathways of irisin in hepatocytes
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Molecular Therapy - Methods & Clinical Development
White adipose tissue (HFD)
NAFLD, Obesity, and Bariatric Surgery
Volume 8, Issue 4, Pages (October 2008)
Omega 3 – Omega 6: What is right for the liver?
Volume 20, Issue 4, Pages (October 2014)
Volume 22, Issue 4, Pages (January 2018)
Volume 134, Issue 2, Pages (February 2008)
NASH: a mitochondrial disease
Volume 11, Issue 5, Pages (May 2010)
Volume 23, Issue 4, Pages (April 2016)
Volume 13, Issue 8, Pages (November 2015)
Volume 138, Issue 2, Pages e1 (February 2010)
Volume 21, Issue 11, Pages (December 2017)
A. Jimoh, Y. Tanko, A. Ahmed, A. Mohammed, J.O. Ayo  Pathophysiology 
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease  Stacey Ruiz, Pablo E. Pergola, Richard.
Playtime Prevents Obesity by Brain-Mediated Fat Browning
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy
Volume 83, Issue 4, Pages (April 2013)
Obesity and the Regulation of Energy Balance
Volume 134, Issue 4, Pages (April 2008)
Role of adiponectin in human skeletal muscle bioenergetics
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Volume 23, Issue 6, Pages (June 2016)
Volume 16, Issue 5, Pages (November 2012)
Volume 134, Issue 2, Pages (February 2008)
Volume 10, Issue 1, Pages (July 2009)
Volume 5, Issue 5, Pages (May 2007)
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Volume 24, Issue 8, Pages e7 (August 2018)
Jieun Lee, Joseph Choi, Susanna Scafidi, Michael J. Wolfgang 
Volume 145, Issue 2, Pages e3 (August 2013)
Volume 23, Issue 6, Pages (June 2016)
Prevention of Steatosis by Hepatic JNK1
Volume 14, Issue 6, Pages (February 2016)
Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects  Kevin M. Korenblat, Elisa.
Volume 20, Issue 4, Pages (October 2014)
Renin–angiotensin system blockade and diabetes: moving the adipose organ from the periphery to the center  Oliver Lenz, Alessia Fornoni  Kidney International 
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Volume 4, Issue 5, Pages (November 2006)
Volume 12, Issue 6, Pages (December 2010)
Volume 25, Issue 12, Pages e6 (December 2018)
Macrophages, Immunity, and Metabolic Disease
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
Volume 18, Issue 3, Pages (January 2017)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 16, Issue 7, Pages (August 2016)
Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression 
Presentation transcript:

Volume 17, Issue 3, Pages 849-861 (October 2016) High-Protein Intake during Weight Loss Therapy Eliminates the Weight-Loss-Induced Improvement in Insulin Action in Obese Postmenopausal Women  Gordon I. Smith, Jun Yoshino, Shannon C. Kelly, Dominic N. Reeds, Adewole Okunade, Bruce W. Patterson, Samuel Klein, Bettina Mittendorfer  Cell Reports  Volume 17, Issue 3, Pages 849-861 (October 2016) DOI: 10.1016/j.celrep.2016.09.047 Copyright © 2016 The Author(s) Terms and Conditions

Cell Reports 2016 17, 849-861DOI: (10.1016/j.celrep.2016.09.047) Copyright © 2016 The Author(s) Terms and Conditions

Figure 1 Changes in Body Weight and Composition and Insulin-Stimulated Glucose Uptake (A–F) Percent changes in body mass (A), intra-hepatic triglyceride (IHTG) content (B), intra-abdominal adipose tissue (IAAT) volume (C), percent contribution of fat-free mass (FFM) to total weight loss (D), and percent changes in absolute (FFM, micromoles per kilogram per minute) and relative (percent) changes in insulin-stimulated glucose rate of disappearance (Rd) (E and F) before and after the diet intervention in the weight-maintenance (WM) group (n = 7) and in subjects who consumed either the standard weight-loss diet (WL; n = 10) or the weight-loss high-protein diet (WL-HP; n = 10). Data are expressed as mean ± SEM. ∗Value significantly different from corresponding value in the WM group (p < 0.05). †Value significantly different from corresponding value in the WL group (p < 0.05). ‡Value significantly different from value in the WM and WL-HP groups (p < 0.05). Cell Reports 2016 17, 849-861DOI: (10.1016/j.celrep.2016.09.047) Copyright © 2016 The Author(s) Terms and Conditions

Figure 2 Intramyocellular Signaling Elements Before and After Weight Loss Weight-loss-induced changes in p-AKTSer473 (A), p-AMPKThr172 (B), p-mTORSer2448 (C), and p-4E-BP1Thr37/46 (D) in muscle during basal, postabsorptive conditions (white bars) and the hyperinsulinemic-euglycemic clamp (black bars) in subjects consuming the standard weight loss (WL) and weight-loss high-protein (WL-HP) diets. Data (n = 6–8) are expressed as mean ± SEM. ∗Value significantly different from corresponding basal value (p < 0.05). †Value significantly different from all other values (p < 0.05). #Significant main effect of clamp (p < 0.05). See also Figure S2. Cell Reports 2016 17, 849-861DOI: (10.1016/j.celrep.2016.09.047) Copyright © 2016 The Author(s) Terms and Conditions

Figure 3 Expression of Genes Involved in Lipogenesis, and Fatty Acid Oxidation and Mitochondrial Function in Muscle (A–L) Expression of genes involved in lipogenesis (A: carbohydrate response element binding protein [CHREBP]; B: elongation of very long-chain fatty acids protein 6 [ELOVL6]; C: fatty acid desaturase 1 [FADS1]; D: fatty acid synthase [FASN]; E: stearyl Co-A desaturase (SCD); and F: sterol regulatory element binding transcription factor 1 [SREBF1]) and in fatty acid oxidation and mitochondrial function (G: acyl-coenzyme A dehydrogenase [ACADM]; H: cytochrome C oxidase subunit IV [COX4/1]; I: carnitine palmitoyl transferase 1 [CPT1B]; J: pyruvate dehydrogenase kinase 4 [PDK4]; K: peroxisome proliferator-activated receptor gamma coactivator 1 alpha [PPARGC1A], and L: uncoupling protein 2 [UCP2]) in muscle before (white bars) and after (black bars) weight loss in subjects consuming the standard weight-loss (WL) diet and weight-loss high-protein (WL-HP) diet. Data (n = 6–9) are expressed relative to the housekeeping gene and presented as mean ± SEM, except for ACADM, FASN1, and SCD, which are expressed as median (quartiles). #Significant main effect of weight loss (p < 0.05). ‡Significant main effect of group (p < 0.05). See also Table S3. Cell Reports 2016 17, 849-861DOI: (10.1016/j.celrep.2016.09.047) Copyright © 2016 The Author(s) Terms and Conditions

Figure 4 Expression of Genes Involved in Inflammatory and Oxidative Stress Defense Pathways in Muscle (A–H) Expression of genes involved in inflammatory (A: cluster of differentiation 68 [CD68]; C: interleukin-6 [IL6]; E: monocyte chemoattractant protein 1 [MCP1]; and G: tumor necrosis factor [TNF]) and oxidative stress defense (B: catalase [CAT]; D: glutathione S-transferase alpha 4 [GSTA4]; F: peroxiredoxin 3 [PRDX3]; and H: superoxide dismutase 1 [SOD1]) pathways before (white bars) and after (black bars) weight loss in subjects consuming the standard weight-loss diet (WL) and weight-loss high-protein (WL-HP) diet. Data (n = 6–9) are expressed relative to the housekeeping gene and presented as mean ± SEM, except for IL6, MCP1, and TNF, which are expressed as median (quartiles). ∗Value significantly different from corresponding basal value (p < 0.05). †Value significantly different from all other values (p < 0.05). #Significant main effect of weight loss (p < 0.05). See also Figure S3 and Table S3. Cell Reports 2016 17, 849-861DOI: (10.1016/j.celrep.2016.09.047) Copyright © 2016 The Author(s) Terms and Conditions